Pharmacogenomic markers of glucorticoid responses in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia

URN:NBN:SI:doc-0LA4NXDE2018Dokmanovic, LidijaDolžan, VitaGasic, VladimirJanić, DraganaJazbec, JanezKotur, NikolaKrstovski, NadaLazic, JelenaPavlovič, SonjaStanković, BiljanaZukic, Brankadocuments/doc/0/URN_NBN_SI_doc-0LA4NXDE_001.pdfdocuments/doc/0/URN_NBN_SI_doc-0LA4NXDE_001.txt352articlestr. 296-306, V1318-20995314476URN:NBN:SI:doc-0LA4NXDEengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYakutna limfoblastna levkemijagenetske spremembeglukokortikoidiotrocizdravljenjePharmacogenomic markers of glucorticoid responses in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia